Mirikizumab Is Effective for Induction and Maintenance of Ulcerative Colitis
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH discuss “Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis,” by D'Haens G, Dubinsky M, Kobayashi T, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455.
Evidence-Based GI: An ACG Publication and Podcast
en-usJanuary 17, 2024